SWAV Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 3.40%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $23,762,678.92

Shockwave Medical Insider Trading History Chart

This chart shows the insider buying and selling history at Shockwave Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$20M$0$20MTotal Insider BuyingTotal Insider Selling

Shockwave Medical Share Price & Price History

Current Price: $334.75
Price Change: +0.30 (1.20%)
As of 05/31/2024 01:00 AM ET

This chart shows the closing price history over time for SWAV up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

SEC Filings (Institutional Ownership Changes) for Shockwave Medical (NASDAQ:SWAV)

95.35% of Shockwave Medical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at SWAV by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
202220232024$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4-$1B$0$1BTotal InflowsTotal Outflows
Shockwave Medical logo
Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina. In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions. Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
Read More on Shockwave Medical

Today's Range

Now: $334.75
Low: $334.75
High: $334.75

50 Day Range

MA: $332.85
Low: $328.87
High: $334.83

52 Week Range

Now: $334.75
Low: $157.00
High: $334.90

Volume

N/A

Average Volume

968,088 shs

Market Capitalization

$12.57 billion

P/E Ratio

78.21

Dividend Yield

N/A

Beta

0.88

Who are the company insiders with the largest holdings of Shockwave Medical?

Shockwave Medical's top insider shareholders include:
  1. Frederic H Moll (Director)
  2. Douglas Evan Godshall (CEO)
  3. Isaac Zacharias (Insider)
  4. Dan Puckett (CFO)
  5. Trinh Phung (VP)
  6. Maria Sainz (Director)
  7. Frank T Watkins (Director)
  8. Sara Toyloy (Director)
  9. Laura Francis (Director)
Learn More about top insider investors at Shockwave Medical.